SCHEMBL1635993

SCHEMBL1635993

CCOC(=O)C1CC12CC1CCC(C)C12

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PPM1B O75688 1/20 0.36
PTPN1 P18031 1/20 0.36
PPP1CC P36873 1/20 0.36
MAPT P10636 2/20 0.34
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
ALDH1A1 P00352 6/20 0.32
FPR2 P25090 1/20 0.31
MEN1 O00255 1/20 0.31
TSHR P16473 1/20 0.31
KMT2A Q03164 1/20 0.31
KDM4E B2RXH2 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
PKM P14618 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1633796 0.74 MAPT (0.35) PPM1BPTPN1PPP1CCMAPTCYP3A4
SCHEMBL1634132 0.68 CYP3A4 (0.40) PPM1BPTPN1PPP1CCMAPTCYP3A4
SCHEMBL1635194 0.68 MAPT (0.38) MAPTCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL1196395 0.67 PPM1B (0.56) PPM1BPTPN1PPP1CCMAPTALDH1A1
SCHEMBL294716 0.67 LMNA (0.43) PPM1BPTPN1PPP1CCMAPTCYP3A4
SCHEMBL30148845 0.67 PPM1B (0.39) PPM1BPTPN1PPP1CCMAPTCYP3A4
SCHEMBL14874442 0.66 PPM1B (0.55) PPM1BPTPN1PPP1CCMAPTALDH1A1
SCHEMBL14874553 0.66 PPM1B (0.55) PPM1BPTPN1PPP1CCMAPTALDH1A1
SCHEMBL14189737 0.66 PPM1B (0.55) PPM1BPTPN1PPP1CCMAPTALDH1A1
SCHEMBL8462991 0.66 ALDH1A1 (0.40) PPM1BPTPN1PPP1CCMAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932245-B2 Spirocyclopropyl amides and acids and their therapeutic applications ABBOTT LABORATORIES (US) 2011-04-26 US disclosed
US-20040204396-A1 Spirocyclopropyl amides and acids and their therapeutic applications ABBVIE INC. 2004-10-14 US disclosed
US-20040077616-A1 Spirocyclopropyl amides and acids and their therapeutic applications ABBOTT LABORATORIES 2004-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040077616-A1 Spirocyclopropyl amides and acids and their therapeutic applications SCN1A, SCN1B, SCN10A PPM1B 1896/4885PTPN1 4456/4885PPP1CC 1712/4885
US-20040204396-A1 Spirocyclopropyl amides and acids and their therapeutic applications SCN1A, SCN1B, SCN10A PPM1B 1896/4885PTPN1 4456/4885PPP1CC 1712/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.